|This article needs additional citations for verification. (September 2009)|
|Traded as||Euronext: DSM|
|Key people||Feike Sijbesma (CEO), Rolf-Dieter Schwalb (CFO), Rob J. Routs (Chairman of the Supervisory Board)|
|Products||Nutritional and pharmaceutical ingredients, performance materials, chemicals for polymer manufacture|
|Revenue||€9.051 billion (2013)|
|Operating income||€749 million (2013)|
|Profit||€271 million (2013)|
|Total assets||€12.017 billion (end 2013)|
|Total equity||€6.098 billion (end 2013)|
|Employees||24,349 (end 2013)|
DSM (in full Koninklijke DSM N.V., or Royal DSM) is a Dutch-based multinational life sciences and materials sciences company. DSM's global end markets include food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM has annual net sales of around €10 billion and employs some 24,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. The company is listed on NYSE Euronext.
DSM was established in 1902 as a state-owned coal mining company. Through the years the company diversified into fertilizers and other chemicals. After 1965, when the Dutch government took the decision to phase out all mining operations in the Netherlands, this diversification was accelerated. By the time the last mine closed (in 1973), DSM had transformed into a chemical company. Since the 1990s DSM has transformed itself again, selling almost all of its commodity chemicals activities and becoming a Life Sciences & Materials Sciences company.
In 1989 the Dutch State floated 70% of its DSM shares on the Amsterdam Stock Exchange (now NYSE Euronext). The remaining 30% were floated in 1996, completing DSM’s privatization. In 1998 the company took over the Dutch food products and biotechnology group Gist-brocades. In 2000 it acquired the US company Catalytica Pharmaceuticals. In 2002 DSM sold its petrochemical division (naphtha crackers and polyolefin plants) to SABIC of Saudi Arabia. In 2003, DSM acquired the nutritional products business (including vitamins) of Roche. In 2005 NeoResins, the coating resins business of Avecia was purchased. In 2010 the Agro and Melamine business groups were sold to Orascom Construction Industries. In January 2011 DSM transferred its anti-infectives business to a 50/50 global joint venture with Sinochem Group, named DSM Sinochem Pharmaceuticals. In February 2011 DSM finalized its acquisition of US based Martek Biosciences Corporation. This acquisition was worth €700 million.
In June 2012 DSM acquired Kensey Nash, a US-based biomedical company primarily focused on regenerative medicine, and the following month it acquired Ocean Nutrition Canada, the leading global provider of fish-oil derived nutritional products to the dietary supplement and food and beverage markets. In December 2012 DSM announced that it had acquired Cargill’s cultures and enzymes business, producing enzymes, polyunsaturated fatty acids (PUFAs), vitamins, cultures, probiotics, bio actives, preservation systems and tests. In the same month, DSM acquired US-based Fortitech. Fortitech provides customized food ingredient blends for the food & beverage, infant nutrition and dietary supplements industries from six production sites located worldwide. In April 2013 DSM acquired Tortuga Companhia Zootécnica Agrária (Tortuga), a Brazilian company manufacturing nutritional supplements for pasture raised beef and dairy cattle.
In November 2013 DSM and JLL Partners announced the creation of a new company, which will be a global contract development and manufacturing organization for the pharmaceutical industry. ‘NewCo’ will be formed by combining DSM’s business group DSM Pharmaceutical Products with Patheon Inc. ‘NewCo’ will be 51% owned by JLL and 49% by DSM.
The name DSM is the initialism of the English translation of the company's original Dutch name, the Nederlandse Staatsmijnen (Dutch State Mines). In the 20th century the state owned company operated four coal mines in the Netherlands: Staatsmijn Wilhelmina, Staatsmijn Emma, Staatsmijn Hendrik and Staatsmijn Maurits. In 1973, after the last mine was closed, the company decided to continue using the initials as its name.
DSM's activities are grouped into four clusters: Nutrition, Pharmaceuticals, Performance Materials and Polymer Intermediates.
In Life Sciences the company is active in Nutrition and Pharma
The Nutrition cluster comprises DSM Nutritional Products and DSM Food Specialties. These nutrition and food ingredients businesses serve the food, feed, cosmetic and pharmaceutical industries. The Nutrition cluster has customized formulation activities in more than 40 locations and a marketing/sales presence reaching over 60 countries. Manufacturing technologies in the Nutrition cluster are largely based on biotechnology, fermentation, chemical process technology and particle engineering. In February 2011 DSM finalized its acquisition of US based Martek Biosciences Corporation for US$1,087 million. This acquisition added new growth platforms for natural, healthy Polyunsaturated Fatty Acids (PUFAs) and nutritional ingredients (Omega-3 DHA and Omega-6 ARA).
The Pharma cluster comprises DSM Pharmaceutical Products and DSM Sinochem Pharmaceuticals (formerly DSM Anti-Infectives). DSM Pharmaceutical Products is a leading independent supplier to the pharmaceutical industry. Many of today’s medicines around the world contain ingredients produced by DSM. The DSM Sinochem Pharmaceuticals joint venture is one of the few penicillin producers outside of China.
In Materials Sciences the company is active in Performance Materials and Polymer Intermediates
The Performance Materials cluster comprises DSM Engineering Plastics, DSM Dyneema and DSM Resins. Their products are used in a wide variety of end-use markets: the automotive industry, the aviation industry, the electrical and electronics industry, the sports and leisure industries, the paint and coatings industry and the construction industry.
Sustainability as business driver
The company is in partnership with the American biofuel company POET to commercially demonstrate and license the manufacture of cellulosic ethanol (a biofuel) from corn crop residue through a biological process using enzymatic hydrolysis followed by fermentation.
Similarly it is in partnership with Roquette Freres for the commercial-scale production of bio-based succinic acid, a chemical used in the food and beverage industry and as a precursor to some specialized polyesters, and currently produced using fossil feedstock.
The company is developing bio-based technologies for the manufacture of pharmaceuticals, food and feed ingredients and ‘green’ materials.
DSM also runs a Nutrition Improvement Program, a business program operated in coordination with DSM’s humanitarian initiative Sight and Life and its partnership with the United Nations’ World Food Programme. For the developed world DSM’s focus is on reducing micronutrient and vitamin deficiency via food fortification and supplementation tailored to specific target groups.
|This section does not cite any references or sources. (April 2013)|
DSM Nutritional Products is the world's largest supplier of nutritional ingredients, such as vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries.
DSM Food Specialties is a manufacturer of food enzymes, cultures, yeast extracts and other specialty ingredients for the global food and beverage industries. DSM Food Specialties supplies advanced ingredients for the food industry, mainly manufactured with the aid of fermentation and enzyme technology, among other technologies. These ingredients are found in well-known food brands for the dairy, baking, fruit juice, beer, wine, savory and functional food segments.
DSM Pharmaceutical Products provides custom contract manufacturing and development services to the pharmaceutical, biopharmaceutical and agrochemical industries. Customers are serviced from five manufacturing sites in the United States and Europe. These customers include pharmaceutical companies and agrochemical multinationals as well as a large number of biotech, specialty and emerging companies across the globe.
DSM Sinochem Pharmaceuticals produces penicillin G and penicillin intermediates (6-APA and 7-ADCA), active pharmaceutical ingredients such as semisynthetic penicillins and semi-synthetic cefalosporins (beta-lactams) and other active pharmaceutical ingredients such as Nystatin and Atorvastatin.
DSM Engineering Plastics manufactures polyamides, polyesters and extrudable adhesive resins. These materials are used mainly in technical components for the electrical and electronics, automotive, engineering and packaging industries.
DSM Dyneema is the inventor and manufacturer of Dyneema ultra-strong fiber. This fiber, based on ultra-high-molecular-weight polyethylene (UHMWPE), is used in many applications in various end-markets, such as life protection, shipping, fishing, offshore, sailing, medical and textiles.
DSM Resins manufactures products used in a wide variety of applications such as paints, wind turbines and automotive. End-markets include building and construction, transport and industry. DSM Resins is also the world's largest manufacturer of fiber optic coatings.
DSM Fibre Intermediates produces caprolactam and acrylonitrile, which are raw materials for synthetic fibers and engineering plastics. Caprolactam is the raw material for polyamide 6, used in textiles, floor coverings, industrial yarns and engineering plastics. Acrylonitrile is a key ingredient for acrylic textile and carpet fibers and for materials (acrylonitrile butadiene styrene, ABS and styrene-acrylonitrile, SAN) for automobile components, electronic devices, toys and sports equipment. Other products include ammonium sulfate (a fertilizer), diaminobutane, sodium cyanide, and cyclohexanone.
- "Annual Report 2013". DSM. Retrieved 26 February 2014.
- "Bloomberg Businessweek company profile". Bloomberg Businessweek. Retrieved 12 November 2012.
- "DSM website". DSM. Retrieved 10 November 2012.
- "DSM in Food, beverages & dietary supplements website". DSM. Retrieved 10 November 2012.
- "DSM in Animal nutrition & health website". DSM. Retrieved 10 November 2012.
- "DSM in Medical website". DSM. Retrieved 10 November 2012.
- "DSM in Automotive / transportation website". DSM. Retrieved 10 November 2012.
- "DSM in Paint & coatings website". DSM. Retrieved 10 November 2012.
- "DSM Bio-based Products & Services". DSM. Retrieved 10 November 2012.
- "Vision 2010 completed".
- Volberda, Henk (2013). Re-inventing Business. Assen: Van Gorcum. p. 270. ISBN 978 90 232 5146 0.
- "DSM Sinochem Pharmaceuticals website". DSM Sinochem Pharmaceuticals. Retrieved 10 November 2012.
- DSM CFO Schwalb: M&A Involves Fair Amount of 'Luck'. Available online. Retrieved on March 20, 2013.
- "Ocean Nutrition Canada website". Ocean Nutrition Canada. Retrieved 10 November 2012.
- "Cargill website". Cargill. Retrieved 8 November 2012.
- "Fortitech website". Fortitech. Retrieved 8 November 2012.
- "Tortuga website (Spanish/Portuguese)". Tortuga. Retrieved 8 November 2012.
- 1902 Staatsmijnen 1952. Heerlen. 1952. p. 410.
- Messing, F.A.M. (1988). De Mijnsluiting in Limburg. Leiden: Nijhoff. p. 224. ISBN 90-6890-241-5.
- "Nutrition Improvement Program website". DSM. Retrieved 19 November 2012.
- "Bloomberg Businessweek company profile DSM Nutritional Products". Bloomberg Businessweek. Retrieved 25 July 2013.
- "Bloomberg Businessweek company profile DSM Food Specialties". Bloomberg Businessweek. Retrieved 25 July 2013.
- "Bloomberg Businessweek company profile DSM Pharmacuticals Inc.". Bloomberg Businessweek. Retrieved 25 July 2013.